NEW OTTERSHAW SURGERY
3 BOUSLEY RISE, OTTERSHAW, CHERTSEY
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 152 | 175 | 86.9% | |
| CKD 4 | 2008 | 153 | 167 | 91.6% | |
| CKD 5 | 2009 | 13 | 15 | 86.7% | |
| CKD 5 | 2010 | 4 | 4 | 100.0% | |
| CKD 5 | 2011 | 5 | 5 | 100.0% | |
| CKD 5 | 2012 | 5 | 5 | 100.0% | |
| CKD 5 | 2013 | 4 | 5 | 80.0% | |
| CKD003 | 2014 | 3 | 3 | 100.0% | |
| CKD003 | 2015 | 2 | 2 | 100.0% | |
| NM84 | 2017 | 3 | 4 | 75.0% | |
| NM84 | 2018 | 6 | 8 | 75.0% | |
| NM84 | 2019 | 4 | 5 | 80.0% | |
| NM84 | 2020 | 5 | 6 | 83.3% | |
| NM84 | 2022 | 7 | 7 | 100.0% | |
| NM84 | 2023 | 15 | 16 | 93.8% |
